Artrya
- Short interest
- 9.83%
- +7.94 pp 30d
- as of 8 Oct 2026
- Reported shorts
- 16.1M
- Shares on issue
- 163.634M
Artrya (AYA) Short Interest
Artrya (ASX:AYA) had 9.83% of shares reported as short positions as of 8 Oct 2026, representing 16,079,661 shares. Artrya operates in the Health Care Equipment & Services industry. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4About Artrya
Artrya Limited is a cutting-edge medical technology company specializing in software that automates the analysis of heart CT scans to aid in the diagnosis of Coronary Artery Disease. Positioned as an innovator in healthcare AI solutions, Artrya focuses on providing accurate, non-invasive diagnostic tools that enhance patient care outcomes. Their offerings are particularly valuable in improving the detection efficiency and accuracy of coronary artery disease assessments.
Company profile →Artrya (ASX:AYA) has 9.83% of its shares on issue reported as short positions as of 8 Oct 2026, or about 16,079,661 shares. Over the past 30 days that figure has risen 7.94 percentage points, and over 90 days it has risen 8.90 percentage points. AYA is classified in the Health Care Equipment & Services industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Short interest
History & FAQ →Weekly context: The 10 most shorted ASX stocks — Week 41, 2026.
Strategy fit
How each stock picker strategy reads AYA today
- Zanger BreakoutWatchScore 9rank 1709 of 1942
- CAN SLIMWatchScore 9rank 1199 of 1541
- Minervini Trend TemplateWatchScore 9rank 1382 of 1716
- Crowded-Short BreakoutSetupScore 39rank 51 of 1502
- Quality compoundersWatchScore 30rank 427 of 1669
Prices to 14 Oct 2026 · Mechanical readings of published rules, not recommendations · Not financial adviceFull strategy readings →
AYA fundamentals
In the year to 30 Jun 2026, Artrya (ASX:AYA) recorded revenue of A$28.0K and a net loss after tax of A$25.2M. A year earlier it recorded revenue of A$28.0K and a net loss after tax of A$16.4M. Year-on-year growth: revenue 0.0% (FY). Net margin −89,939.3%, return on equity −50.6% (FY). Figures are in AUD, the company's reporting currency; source: Yahoo Finance, as at 14 Oct 2026.
Full statements, ratios and filings are on the Financials tab. Not financial advice.
Latest AYA news
All news- Notice of Annual General Meeting/Proxy Form
asx · 13 Oct 2026
- Application for quotation of securities - AYA
asx · 5 Oct 2026
- Issue of Shares on Exercise of Securities & Cleansing Notice
asx · 5 Oct 2026
Company details
More Health Care Equipment & Services Stocks
Other shorted stocks in this sector
Be the first to discuss AYA
Start a research thread or post the first pulse update